127 related articles for article (PubMed ID: 25689664)
1. Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment.
Wang L; Jian Y; Yang G; Gao W; Wu Y; Zuo L
Clin J Oncol Nurs; 2015 Feb; 19(1):E4-7. PubMed ID: 25689664
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study.
Kondo M; Hotta Y; Yamauchi K; Sanagawa A; Komatsu H; Iida S; Kimura K
BMC Cancer; 2020 Nov; 20(1):1117. PubMed ID: 33203424
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous tumor lysis syndrome (STLS) during biopsy for burkitt lymphoma: a case report.
Pan S; Shen Q; Zhou J; Li T
BMC Pediatr; 2024 Mar; 24(1):209. PubMed ID: 38521927
[TBL] [Abstract][Full Text] [Related]
4. Tumour lysis syndrome in a neonate with transient abnormal myelopoiesis.
Mohammad Khuzaini A; Mohd Baharudin JA; Md Fauzi A; Zulkeflee HA; Abdul Halim H; Mazli SK; Osman NFB
J Neonatal Perinatal Med; 2024; 17(2):269-273. PubMed ID: 38728206
[TBL] [Abstract][Full Text] [Related]
5. Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies.
McBride A; Trifilio S; Baxter N; Gregory TK; Howard SC
J Adv Pract Oncol; 2017; 8(7):705-720. PubMed ID: 30333933
[No Abstract] [Full Text] [Related]
6. Acute non-myelosuppressive complications of systemic anticancer therapy.
Rea D
Clin Med (Lond); 2008 Aug; 8(4):439-42. PubMed ID: 18724616
[No Abstract] [Full Text] [Related]
7. How I Treat Tumor Lysis Syndrome.
Joseph A; Zafrani L
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1634-1636. PubMed ID: 37788006
[No Abstract] [Full Text] [Related]
8. Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.
Delforge M; Minuk L; Eisenmann JC; Arnulf B; Canepa L; Fragasso A; Leyvraz S; Langer C; Ezaydi Y; Vogl DT; Giraldo-Castellano P; Yoon SS; Zarnitsky C; Escoffre-Barbe M; Lemieux B; Song K; Bahlis NJ; Guo S; Monzini MS; Ervin-Haynes A; Houck V; Facon T
Haematologica; 2015 Jun; 100(6):826-33. PubMed ID: 25769541
[TBL] [Abstract][Full Text] [Related]
9. TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
Chittani M; Zaninello R; Lanzani C; Frau F; Ortu MF; Salvi E; Fresu G; Citterio L; Braga D; Piras DA; Carpini SD; Velayutham D; Simonini M; Argiolas G; Pozzoli S; Troffa C; Glorioso V; Kontula KK; Hiltunen TP; Donner KM; Turner ST; Boerwinkle E; Chapman AB; Padmanabhan S; Dominiczak AF; Melander O; Johnson JA; Cooper-Dehoff RM; Gong Y; Rivera NV; Condorelli G; Trimarco B; Manunta P; Cusi D; Glorioso N; Barlassina C
J Hypertens; 2015 Jun; 33(6):1301-9. PubMed ID: 25695618
[TBL] [Abstract][Full Text] [Related]
10. Labetalol for hypertension in pregnancy.
Magee LA; Namouz-Haddad S; Cao V; Koren G; von Dadelszen P
Expert Opin Drug Saf; 2015 Mar; 14(3):453-61. PubMed ID: 25692529
[TBL] [Abstract][Full Text] [Related]
11. Untypical amlodipine-induced gingival hyperplasia.
Pavlic V; Zubovic N; Ilic S; Adamovic T
Case Rep Dent; 2015; 2015():756976. PubMed ID: 25692048
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users.
Shimada Y; Nagahara A; Hojo M; Asaoka D; Sasaki H; Ueyama H; Matsumoto K; Watanabe S
Gastroenterol Res Pract; 2015; 2015():252963. PubMed ID: 25691897
[TBL] [Abstract][Full Text] [Related]
13. Successful control of radicular pain in a pediatric patient with Guillain-Barré syndrome.
Kajimoto M; Koga M; Narumi H; Inoue H; Matsushige T; Ohga S
Brain Dev; 2015 Oct; 37(9):897-900. PubMed ID: 25690256
[TBL] [Abstract][Full Text] [Related]
14. Paracetamol overdose.
Skinner A
Nurs Stand; 2015 Feb; 29(25):61. PubMed ID: 25690237
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
Mai EK; Bertsch U; Dürig J; Kunz C; Haenel M; Blau IW; Munder M; Jauch A; Schurich B; Hielscher T; Merz M; Huegle-Doerr B; Seckinger A; Hose D; Hillengass J; Raab MS; Neben K; Lindemann HW; Zeis M; Gerecke C; Schmidt-Wolf IG; Weisel K; Scheid C; Salwender H; Goldschmidt H
Leukemia; 2015 Aug; 29(8):1721-9. PubMed ID: 25787915
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T; Huang H; Jin J; Zhu J; Liu T; Samoilova O; Pylypenko H; Verhoef G; Siritanaratkul N; Osmanov E; Alexeeva J; Pereira J; Drach J; Mayer J; Hong X; Okamoto R; Pei L; Rooney B; van de Velde H; Cavalli F;
N Engl J Med; 2015 Mar; 372(10):944-53. PubMed ID: 25738670
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib treatment for patients with mantle-cell lymphoma.
Tanday S
Lancet Oncol; 2015 Apr; 16(4):e162. PubMed ID: 25773171
[No Abstract] [Full Text] [Related]
18. [Methotrexate and psoriasis: about 46 cases].
Inani K; Meziane M; Mernissi F
Pan Afr Med J; 2014; 19():84. PubMed ID: 25709742
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.
Leblebjian H; Noonan K; Paba-Prada C; Treon SP; Castillo JJ; Ghobrial IM
Am J Hematol; 2015 Jun; 90(6):E122-3. PubMed ID: 25703132
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
